Ozempic and Fiasp drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Fiasp (insulin aspart). Common drug interactions include palpitations among females and blood glucose decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Fiasp. It is created by eHealthMe based on reports of 60 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Fiasp?

Fiasp has active ingredients of insulin aspart. eHealthMe is studying from 2,110 Fiasp users. Check the latest studies of Fiasp.

On Jul, 30, 2026

60 people who take Ozempic and Fiasp together, and have interactions are studied.

What are the common drug interactions of Ozempic and Fiasp, by gender? *:

female:

Palpitations (feelings or sensations that your heart is pounding or racing)
Productive cough
Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
Rash
Renal failure (kidney dysfunction)
Respiratory tract congestion (blockage on respiratory system)
Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
Retinal haemorrhage (bleeding from retina)
Rotator cuff syndrome (a spectrum of conditions affecting the rotator cuff tendons of the shoulder)
Sepsis (a severe blood infection that can lead to organ failure and death)

male:

Blood glucose decreased
Blood glucose increased
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Weight decreased
Cold sweat
Constipation
Decreased appetite
Delirium (wild excitement)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Injection site scab

What are the common drug interactions of Ozempic and Fiasp, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Diabetic dyslipidaemia (cardiovascular disease in diabetes mellitus)
Weight decreased
Decreased appetite

40-49:

Abdominal pain upper
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Nausea (feeling of having an urge to vomit)
Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)

50-59:

Chest discomfort
Diarrhoea
Dyspnoea (difficult or laboured respiration)
Eructation (release of gas from the digestive tract)
Nausea (feeling of having an urge to vomit)
Pancreatic carcinoma metastatic (pancreatic cancer- metastatic)
Abdominal discomfort
Lethargy (tiredness)
Weight increased
Blood glucose decreased

60+:

Hypoglycaemia (deficiency of glucose in the bloodstream)
Blood glucose decreased
Abdominal pain
Anxiety
Cellulitis (infection under the skin)
Diarrhoea
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Insomnia (sleeplessness)
Application site pain
Arthralgia (joint pain)

What are the existing conditions these people have? *

Type 2 Diabetes: 25 people, 41.67%
Type 1 Diabetes: 5 people, 8.33%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 6.67%
Hyperglycemia (high blood sugar): 4 people, 6.67%
Diabetes: 4 people, 6.67%
Ankylosing Spondylitis (type of arthritis affecting the spine): 4 people, 6.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Fiasp?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously